U.S. With states facing deadlines to order coronavirus vaccines, California went into lockdown again and federal officials advised wearing masks indoors, new infection records reached 227,885 on Friday.
Many states are reporting record infections, hospitalizations and deaths, leading to healthcare systems breaking points. The number of Americans hospitalized in Covid-19 reached a record high of 100,667 on Thursday.
The average daily number of cases on Friday is 210,000 and the average daily death is 1,800, with 2,607 deaths recorded on Friday, according to Johns Hopkins University. U.S. In all, more than 14 million cases have been reported.
This worrying trend is attributed to the millions who choose to travel and collect on the Thanksgiving holiday.
“People were less willing to change their behavior than he was [on] There is no other day during the epidemic, ”Laura Skivel, founder of analytics company Streetlight Data, told the Associated Press.
As he continues to fight his crucial presidential election unopposed by JJ Biden, Donald Trump will face growing criticism for his lack of leadership.
The Feder Centers for Disease Control and Prevention (CDC) has set Friday as the deadline for states to order a two-phase job in order to authorize an emergency that could give a green light to a vaccine produced by Pfizer.
U.S. on Saturday. James, a member of the Food and Drug Administration’s (FDA) Vaccine Advisory Committee and president and chief executive of Mehri Medical College. James Hildreth said NBC vaccinations could begin soon after the crucial meeting.
“We will spend the day on Thursday reviewing Pfizer’s data and a vote will be taken at the end of the day,” he said. “So by the end of the day next Thursday, a decision on the vaccine can be made.
“If the FDA commissioner decides to approve … the day when the vote is taken, we will be able to see vaccinations across the country early Friday next week.”
The World Health Organization has warned governments and citizens not to leave their guard even when vaccination is imminent, saying healthcare systems can still be nonsense, and recent data suggests that, despite being rare, re-adjustment is possible.
“We’ve seen an increase in the number of people infected, but we’re also seeing data coming out that protection can’t be a lifetime, and so we can see that re. The reinstatement begins. , Told reporters in Geneva on Friday.
Britain has approved the Pfizer vaccine, raising hopes that recruitment against the virus, which has killed nearly 1.5 million people worldwide, could come soon. But it has also come with controversy, US expert Dr. Anthony Fawcett later retracted the view that British officials had not properly analyzed the data.
Fawcett, a member of the White House task force, said Friday that healthy Americans should not expect to receive the vaccine until April, as health care workers, the elderly and people with chronic health conditions will be given priority.
“The chances of a healthy non-elderly person not having the expected underlying conditions begin in late March, early April. Once you arrive in April, there is probably a complete explosion with those individuals. Fawcett told CNN.
“The sooner you vaccinate the overwhelming majority of the country, the sooner you’ll get the umbrella of animal immunity, which is very important for bringing the virus level down,” he said.
The first vaccine shipment is expected to be distributed to state and federal agencies, including the Department of Defense. A Reuters analysis found that the first attempt to protect high-priority groups, such as health care workers, would fall short.
Writing for Dispatch, Marty McCurry, a professor at the Conservative magazine Martin Hopkins, said the FDA should “adopt a sense of urgency.”
“We have had the pace of Operation Warlord in developing vaccines, but we have Operation Operation Turtle Speed in reviewing the results,” he wrote.
Experts also warn that there are still many unknowns about Pfizer, Moderna and AstraZeneca vaccine candidates, including the duration of immunity, potential long-term side effects and variations in age, race and species.
On Thursday, Dr. William Moss, executive director of the Johns Hopkins Bloomberg School of Public Health’s International Vaccine Center Access Center, said it would probably take a year or more to understand what the vaccine could do.
“It will be important to move forward with the individuals receiving the vaccine,” he said. “Other vaccines … might be better.”
Not enough time has elapsed to determine if the vaccine has long-term side effects that could stop transmission, Moss said, “We will only know the short-term side effects.”
Rupali Limaye, director of behavioral and applied sciences at the International Vaccine Center Access Center, said people would not be able to save lives if covid vaccines were not given to most people. It is currently estimated that the U.S. 70% of the population must be vaccinated against herd immunizations.
Limaye said health and health care officials must begin to identify potential barriers to comprehensive vaccination, including a disparity of trust between white and non-white populations.
He said, “Messages have to be given to consider issues like hesitation so that appropriate intervention can be implemented.” “It should be tailored to meet different audiences and be reliable and transparent.”
